Visa Forecast, price target & analysts
Visa Target price 2025 - Analyst rating & recommendation
Visa Classifications & Recommendation:
Visa Price Target
| Target Price | $408.00 |
| Price | $329.61 |
| Potential | 23.78% |
| Number of Estimates | 40 |
| 40 Analysts have issued a price target Visa 2026 . The average Visa target price is $408.00. This is 23.78% higher than the current stock price. The highest price target is $472.50 43.35% , the lowest is $313.56 4.87% . | |
| A rating was issued by 47 analysts: 39 Analysts recommend Visa to buy, 8 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Visa stock has an average upside potential 2026 of 23.78% . Most analysts recommend the Visa stock at Purchase. |
Sales and Margin forecast 2026, 2027 & 2028
42 Analysts have issued a sales forecast Visa 2026 . The average Visa sales estimate is $45.3b . This is 13.34% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $47.3b 18.24% , the lowest is $43.2b 8.06% .
This results in the following potential growth metrics:
Revenue Estimates
| 2025 | $40.0b | 11.34% |
|---|---|---|
| 2026 | $45.3b | 13.34% |
| 2027 | $49.9b | 10.12% |
| 2028 | $54.6b | 9.31% |
29 Analysts have issued an Visa EBITDA forecast 2026. The average Visa EBITDA estimate is $31.8b . This is 14.56% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $34.0b 22.31% , the lowest is $29.6b 6.55% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2025 | $27.8b | 10.70% |
|---|---|---|
| 2026 | $31.8b | 14.56% |
| 2027 | $35.1b | 10.44% |
| 2028 | $38.8b | 10.45% |
| 2029 | $42.5b | 9.55% |
EBITDA Margin
| 2025 | 69.44% | 0.57% |
|---|---|---|
| 2026 | 70.19% | 1.08% |
| 2027 | 70.39% | 0.28% |
| 2028 | 71.13% | 1.05% |
43 Visa Analysts have issued a net profit forecast 2026. The average Visa net profit estimate is $25.0b . This is 26.15% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $26.1b 31.69% , the lowest is $23.8b 20.07% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2025 | $19.9b | 2.04% |
|---|---|---|
| 2026 | $25.0b | 26.16% |
| 2027 | $28.3b | 12.80% |
| 2028 | $31.8b | 12.43% |
Net Margin
| 2025 | 49.64% | 8.35% |
|---|---|---|
| 2026 | 55.25% | 11.31% |
| 2027 | 56.60% | 2.44% |
| 2028 | 58.21% | 2.84% |
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029
43 Analysts have issued a Visa forecast for earnings per share. The average Visa EPS is $13.05 . This is 27.82% higher than earnings per share in the financial year 2025. The highest EPS forecast is $13.62 33.40% , the lowest is $12.42 21.65% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2025 | $10.09 | 5.32% |
|---|---|---|
| 2026 | $13.05 | 29.34% |
| 2027 | $14.72 | 12.80% |
| 2028 | $16.55 | 12.43% |
| 2029 | $19.11 | 15.47% |
P/E ratio
| Current | 32.28 | 0.51% |
|---|---|---|
| 2026 | 25.27 | 21.73% |
| 2027 | 22.40 | 11.36% |
| 2028 | 19.92 | 11.07% |
Based on analysts' sales estimates for 2026, the Visa stock is valued at an EV/Sales of 14.05 and an P/S ratio of 13.92 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 15.93 | 8.13% |
|---|---|---|
| 2026 | 14.05 | 11.78% |
| 2027 | 12.76 | 9.19% |
| 2028 | 11.67 | 8.52% |
P/S ratio
| Current | 15.77 | 8.23% |
|---|---|---|
| 2026 | 13.92 | 11.77% |
| 2027 | 12.64 | 9.19% |
| 2028 | 11.56 | 8.52% |
Current Visa Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Buy
➜
Buy
|
Unchanged | Oct 29 2025 |
| Macquarie |
Outperform
➜
Outperform
|
Unchanged | Oct 29 2025 |
| Raymond James |
Outperform
➜
Outperform
|
Unchanged | Oct 29 2025 |
| Wells Fargo |
➜
Overweight
|
Initiated | Oct 22 2025 |
| Citigroup |
➜
Buy
|
Initiated | Oct 22 2025 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Oct 06 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Jul 31 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Buy
➜
Buy
|
Oct 29 2025 |
|
Unchanged
Macquarie:
Outperform
➜
Outperform
|
Oct 29 2025 |
|
Unchanged
Raymond James:
Outperform
➜
Outperform
|
Oct 29 2025 |
|
Initiated
Wells Fargo:
➜
Overweight
|
Oct 22 2025 |
|
Initiated
Citigroup:
➜
Buy
|
Oct 22 2025 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Oct 06 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jul 31 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
